Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Changes in Stockholders??? Equity

v3.26.1
Condensed Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Loss
Non- controlling Interests
Beginning balance at Dec. 31, 2024 $ 891,272 $ 315 $ 742,072 $ 312,765 $ (69,776) $ (93,669) $ (435)
Beginning balance (in shares) at Dec. 31, 2024   28,628          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share award amortization 3,550 $ 2 3,548        
Share award amortization (in shares)   225          
Share repurchases (in shares)   (78)          
Share repurchases (2,495)       (2,495)    
Exercise of stock options 2   2        
Net income (loss) 27,381     27,359     22
Other comprehensive loss 11,593         11,593  
Ending balance at Mar. 31, 2025 931,303 $ 317 745,622 340,124 (72,271) (82,076) (413)
Ending balance (in shares) at Mar. 31, 2025   28,775          
Beginning balance at Dec. 31, 2025 $ 1,059,623 $ 325 762,520 441,739 (87,129) (57,750) (82)
Beginning balance (in shares) at Dec. 31, 2025 29,177 29,177          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share award amortization $ 3,955 $ 7 3,948        
Share award amortization (in shares)   645          
Share repurchases (in shares)   (240)          
Share repurchases (11,028)       (11,028)    
Exercise of stock options 519 $ 24 519        
Net income (loss) 13,065     13,106     (41)
Dividends declared on common stock (3,821)     (3,821)      
Other comprehensive loss (3,446)         (3,446)  
Ending balance at Mar. 31, 2026 $ 1,058,867 $ 332 $ 766,987 $ 451,024 $ (98,157) $ (61,196) $ (123)
Ending balance (in shares) at Mar. 31, 2026 29,606 29,606